In a Second Suit, Lupin Atlantis Holdings Sues Apotex and Ethypharm
March 23, 2011
Lupin Atlantis Holdings filed suit against Apotex and Ethypharm over two patents related to pharmaceutical compositions comprising micronized fenofibrate to treat patient conditions of hypertriglyceridemia and/or hypercholesterolemia and/or hyperlipidemia. 3/18, District of Delaware, 1:2011cv00234
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
